The changing landscape of HER2-positive Breast Cancer
For several years we have approached a ‘standard of care’ (SOC) for the treatment of metastatic HER2-positive breast cancer....
Biomarker for Early Detection of Pancreatic Cancer
Pancreatic cancer is one of the leading causes of cancer-related death. Despite advanced treatment regimens, the 5-year survival rate...
Avapritinib approved by FDA for use in systemic mastocytosis
On June 16, 2021, the FDA approved a new targeted drug for advanced systemic mastocytosis, a group of rare...
Dapagliflozin approved for use in chronic kidney disease
The SGLT2 inhibitors, or gliflozins, have been rising stars in the fields of endocrinology and cardiology for their ability...
Metastasis Prevention – A New Weapon in the Fight Against Cancer
Despite years of research, cancer metastasis always remains incurable and fatal. There are no approved drugs for the prevention...
Panelist Diaries: Why do our sporting heroes suddenly collapse with heart attacks?
When the Danish footballer Christian Eriksen collapsed from a cardiac arrest on Saturday 12th June 2021, the world was...
FDA approves Qelbree, a Non-stimulant Treatment for ADHD
The FDA has approved Qelbree (SPN-812), for children aged 6 to 17 years with attention deficit hyperactivity disorder (ADHD)....
CAR-T Therapy Approved for B-Cell Non-Hodgkin Lymphoma
Non-Hodgkin lymphoma treatment traditionally relied on chemotherapy, radiation, and bone marrow transplant. More recently, immuno-oncology treatments have come to...
A new device for mild sleep apnea
Most non-surgical options for managing mild sleep apnea simply keep the airway open while the individual sleeps. A new...
Gene therapies in the pipeline for hereditary eye diseases
Gene therapies for blindness have recently been in the news. There has been much interest in the potential for...